Cancerppd 2.0 The anticancer peptide database serves as a critical resource for researchers investigating novel peptide-based cancer therapeutics. These curated repositories compile experimentally verified anticancer peptides (ACPs) and their associated data, offering valuable insights into their sequences, lengths, structures, and mechanisms of action.Anticancer peptides Initiatives like CancerPPD, CancerPPD2, DCTPep, and ApInAPDB represent significant efforts to organize and disseminate this vital information, accelerating the discovery and development of new cancer treatments.
Several prominent databases have emerged to catalog anticancer peptides, each with unique strengths and focuses.
* CancerPPD is a foundational repository that provides a comprehensive collection of experimentally verified anticancer peptides and proteins.Welcome To DCTPep It has been instrumental in centralizing data, enabling researchers to search and browse through a significant number of known ACPs. Its subsequent version, CancerPPD2, builds upon this by offering an updated and expanded dataset, reflecting the latest research and discoveries in the fieldCancerPPD: A database of anticancer peptides and proteins.
* DCTPep (Data of Cancer Therapy Peptides) is another important resource, specifically focusing on peptides with therapeutic potential against cancer. It is structured into sub-libraries for peptides and drugs, offering a dual perspective for drug discovery and development.
* ApInAPDB (Apoptosis-Inducing Anticancer Peptides Database) specifically targets peptides that induce apoptosis, a programmed cell death pathway crucial for eliminating cancer cells. This focused approach provides specialized data for researchers interested in this particular mechanism of action.Broad Institute
* PeptiHub is a more recent addition, aiming to be a comprehensive database with precisely annotated cancer-related peptide data, boasting a large number of unique peptides and records.
These databases are essential for several reasons.CancerPPD is a first and unique database of its kind, whichprovides comprehensive information about anticancer peptides/proteins and the targeted cell lines . They consolidate information that would otherwise be scattered across numerous research papers, saving researchers considerable time and effortCancerPPD. By providing standardized data formats, they facilitate comparative analysis and the identification of patterns that might not be apparent from isolated studies. Furthermore, they serve as a valuable starting point for in silico prediction models and experimental validation, guiding the direction of future research.
A crucial aspect of these anticancer peptide databases is their emphasis on experimentally verified anticancer peptides作者:M Xie·2020·被引用次数:288—Anti-cancer peptides(ACPs) are a series of shortpeptidescomposed of 10–60 amino acids that can inhibit tumour cell proliferation or .... This ensures that the data reflects real-world efficacy and biological activity, rather than theoretical predictions. Such verified data is paramount for building reliable predictive models and for guiding the selection of candidate peptides for further preclinical and clinical development.Identification of subtypes of anticancer peptides based on ... The inclusion of details such as experimental techniques used, sequence information, and target cell lines provides a rich context for understanding the peptides' properties and potential applications.
The ongoing development and expansion of anticancer peptide databases are vital for the advancement of peptide-based cancer therapies.DRACP: a novel method for identification of anticancer peptides As more data is collected and curated, these resources will become even more powerful tools for identifying novel ACPs, understanding their structure-activity relationships, and designing more effective and targeted cancer treatments. Initiatives that integrate artificial intelligence and machine learning with these databases hold particular promise for accelerating the discovery process, enabling the prediction of new therapeutic peptides with enhanced efficacy and reduced side effects作者:Y Li·2023·被引用次数:22—Cancer is one of the most dangerous diseases, it annually kills millions of people globally.Anticancer peptides can treat cancer with small side effects.. The ultimate goal is to leverage these comprehensive databases to translate promising peptide candidates into life-saving treatments for cancer patients作者:A Tyagi·2014·被引用次数:428—CancerPPD(http://crdd.osdd.net/raghava/cancerppd/) is a repository of experimentally verified anticancer peptides (ACPs) and anticancer proteins..
Join the newsletter to receive news, updates, new products and freebies in your inbox.